CCL18 and diabetes mellitus: In patients with newly diagnosed T2DM, activation of the anti-inflammatory response was maintained; however, there was a significant (p < 0.001) decrease in the stimulated secretion of CCL18 in patients with a diabetes duration of more than 10 years.